Atlas Arteria (ALX)

Currency in AUD
4.27
-0.02(-0.47%)
Closed·
High dividend Yield
ALX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.264.33
52 wk Range
4.215.54
Key Statistics
Bid/Ask
4.32 / 4.32
Prev. Close
4.27
Open
4.3
Day's Range
4.26-4.33
52 wk Range
4.21-5.54
Volume
1.15M
Average Vol. (3m)
2.4M
1-Year Change
-11.5942%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.97
Upside
+16.39%
Members' Sentiments
Bearish
Bullish
ProTips
Pays a significant dividend to shareholders

Atlas Arteria News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Atlas Arteria Limited owns, develops, and operates toll roads in France, Germany, Australia, Bermuda, and the United States. It holds 30.82% interest in the APRR motorway network, 30.85% interest in the ADELAC commuter road, and 30.79% interest in the A79 transversal link located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago, United States; and 100% interest in the Dulles Greenway located in Virginia, United States. Atlas Arteria Limited was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. The company was incorporated in 2009 and is based in Melbourne, Australia.

Atlas Arteria Earnings Call Summary for H2/2025

  • Proportional toll revenue rose 9.4% YoY with EBITDA up 9.3%; maintained stable 75% margin despite France's temporary supplemental tax impact
  • Confirmed AUD 0.40 distribution per security for 2025 and 2026; payout ratio expected at top of 90-110% range due to extended French tax
  • Stock gained 2.89% to AUD 4.98 with 13.3% YTD return; offers 7.43% dividend yield but InvestingPro suggests potential overvaluation concerns
  • Implemented new FX hedging program to manage EUR/AUD volatility; corporate cash balance stood at AUD 151M with AUD 549M received from operations
  • Expects return to policy payout range post-2026 as free cash flow grows; faces risks from French regulatory changes and currency fluctuations
Last Updated: 02/25/2026, 07:17 PM
Read Full Transcript
Atlas Arteria investor slides for H2/2025
Atlas Arteria 2025 slides
Last Update: Feb 26, 2026
See full investor slides

Compare ALX to Peers and Sector

Metrics to compare
ALX
Peers
Sector
Relationship
P/E Ratio
0.0x14.7x12.5x
PEG Ratio
0.000.150.03
Price / Book
0.0x1.3x1.4x
Price / LTM Sales
0.0x5.3x1.3x
Upside (Analyst Target)
0.0%19.8%19.8%
Fair Value Upside
Unlock1.1%5.9%Unlock

Analyst Ratings

3 Buy
5 Hold
4 Sell
Ratings:
12 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 4.97
(+16.39% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
RBC Capital
Hold5.00+17.10%5.25MaintainMar 03, 2026
RBC Capital
Hold5.25+22.95%5.50MaintainFeb 04, 2026
Jefferies
Buy5.91+38.41%6.39MaintainOct 22, 2025
Citi
Buy5.70+33.49%5.80MaintainSep 01, 2025
Jefferies
Buy6.39+49.65%6.42MaintainAug 28, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.18%
Dividend Yield
9.32%
Industry Median 4.24%
Annualized Payout
0.40
Paid unevenly
5-Years Growth
+10.76%
Growth Streak

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
0.10 / --
Revenue / Forecast
82.5M / 199M
EPS Revisions
Last 90 days

ALX Income Statement

People Also Watch

20.17
SGM
-2.28%
5.000
QUB
+0.60%
22.13
ALQ
+1.00%
41.410
SGH
-1.43%
4.79
IFL
0.00%

FAQ

What Is the Atlas Arteria (ALX) Stock Price Today?

The Atlas Arteria stock price today is 4.27 AUD.

What Stock Exchange Does Atlas Arteria Trade On?

Atlas Arteria is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Atlas Arteria?

The stock symbol for Atlas Arteria is "ALX."

Does Atlas Arteria Pay Dividends? What’s The Current Dividend Yield?

The Atlas Arteria dividend yield is 9.37%.

What Is the Atlas Arteria Market Cap?

As of today, Atlas Arteria market cap is 6.20B AUD.

What Is Atlas Arteria's Earnings Per Share (TTM)?

The Atlas Arteria EPS (TTM) is 0.18.

From a Technical Analysis Perspective, Is ALX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Atlas Arteria Stock Split?

Atlas Arteria has split 2 times.

What is the current trading status of Atlas Arteria (ALX)?

As of Apr 15, 2026, Atlas Arteria (ALX) is trading at a price of 4.27 AUD, with a previous close of 4.27 AUD. The stock has fluctuated within a day range of 4.26 AUD to 4.33 AUD, while its 52-week range spans from 4.21 AUD to 5.54 AUD.

What Is Atlas Arteria (ALX) Price Target According to Analysts?

The average 12-month price target for Atlas Arteria is 4.97 AUD, with a high estimate of 5.56 AUD and a low estimate of 4.31 AUD. 3 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an +16.39% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.